Sino Biopharmaceutical Ltd Sustainability Reports
Sino Biopharmaceutical Limited is an investment holding company engaged in the research, development, manufacture, and sale of innovative medicines, biologics, and high-end generic drugs. Its core therapeutic focuses cover oncology, liver/cardiometabolic diseases, respiratory/autoimmune diseases, and surgery/analgesia.
Sector: Manufacturing
Country: Hong Kong
Exchange: Hong Kong Stock Exchange
ISIN: KYG8167W1380
25 reports from 2008 to 2025